MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Clinical trials for MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bacteria bombs target Hard-to-Treat tumors in new combo therapy
Disease control OngoingThis early-phase study tests a special bacteria (Clostridium novyi-NT) injected directly into tumors, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors that haven't responded to standard treatments. The goal is to find the safest dose and s…
Matched conditions: MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
Do cancer patients and doctors see Eye-to-Eye on recovery goals?
Knowledge-focused OngoingThis study looks at whether cancer patients and their doctors have similar expectations about how well patients will move and care for themselves after a short stay in inpatient rehabilitation. About 133 adults with any type of cancer who can handle 3 hours of rehab daily are tak…
Matched conditions: MALIGNANT NEOPLASMS OF INDEPENDENT (PRIMARY) MULTIPLE SITES
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC